Aritro Nath

Also affiliated with City of Hope

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 1%percentile

5.0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen

Nature Communications(2019)10.1038/s41467-019-09799-2

Top 4%

5.0DataRank

Top 4%368 citations

Dennis Wang, Mike J. Mason, Bence Szalai, Krishna C. Bulusu, Yuanfang Guan +426 more

Papers

Driven by 20 papers — median percentile 96. Top paper: “Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen”.

Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen

Nature Communications(2019)10.1038/s41467-019-09799-2

Top 4%

5.0DataRank

Top 4%368 citations

Dennis Wang, Mike J. Mason, Bence Szalai, Krishna C. Bulusu, Yuanfang Guan +426 more

Exploiting collateral sensitivity controls growth of mixed culture of sensitive and resistant cells and decreases selection for resistant cells in a cell line model

Cancer Cell International(2020)10.1186/s12935-020-01337-1

N/A

0DataRank · unranked

25 citations

Jinfeng Chen, Rena Emond, Patrick A. Cosgrove, Lance Pflieger, Aritro Nath +3 more

A `one-two punch' therapy strategy to target chemoresistance in estrogen receptor positive breast cancer

Translational Oncology(2020)10.1016/j.tranon.2020.100946

N/A

0DataRank · unranked

17 citations

Jiayi Liu, Samuel W. Brady, Patrick A. Cosgrove, Aritro Nath, Jasmine A. McQuerry +6 more

Palmitate-Induced IRE1–XBP1–ZEB Signaling Represses Desmoplakin Expression and Promotes Cancer Cell Migration

Molecular Cancer Research(2020)10.1158/1541-7786.mcr-19-0480

N/A

0DataRank · unranked

25 citations

Amrita Oak, Kevin Y. Chen, Irene Li, R. Chauncey Splichal, Jason Portis +4 more

Exploiting collateral sensitivity controls growth of mixed culture of sensitive and resistant cells and decreases selection for resistant cells

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.05.07.082073

N/A

0DataRank · unranked

2 citations

Jinfeng Chen, Rena Emond, Patrick A. Cosgrove, Lance Pflieger, Aritro Nath +3 more

A ‘one-two punch’ therapy strategy to target chemoresistance in estrogen receptor positive breast cancer

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.03.12.989251

N/A

0DataRank · unranked

1 citations

Jiayi Liu, Samuel W. Brady, Patrick A. Cosgrove, Aritro Nath, Jasmine A. McQuerry +6 more

Ecological interactions in breast cancer: Cell facilitation promotes growth and survival under drug pressure

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.02.01.429214

N/A

0DataRank · unranked

8 citations

Jason I. Griffiths, Vince Kornél Grolmusz, Aritro Nath, Jinfeng Chen, Eric F. Medina +4 more

ENDORSE: a prognostic model for endocrine therapy response in advanced estrogen-receptor positive breast cancers

medRxiv(2021)10.1101/2021.02.03.21251035

N/A

0DataRank · unranked

0 citations

Adam L. Cohen, Andrea Bild, Aritro Nath

RAGE Inhibitors as Alternatives to Dexamethasone for Managing Cerebral Edema Following Brain Tumor Surgery

Neurotherapeutics(2022)10.1007/s13311-022-01207-w

N/A

0DataRank · unranked

15 citations

Yanyan Song, Ian Y. Zhang, Leying Zhang, Hang Gao, Yanping Su +12 more

A machine learning framework for scRNA-seq UMI threshold optimization and accurate classification of cell types

Frontiers in Genetics(2022)10.3389/fgene.2022.982019

N/A

0DataRank · unranked

6 citations

Jinfeng Chen, Jason I. Griffiths, Andrea H. Bild, Aritro Nath, Isaac Bishara

ENDORSE: a prognostic model for endocrine therapy in estrogen‐receptor‐positive breast cancers

Molecular Systems Biology(2022)10.15252/msb.202110558

N/A

0DataRank · unranked

12 citations

Adam L. Cohen, Andrea Bild, Aritro Nath

Predicting clinical response to everolimus in ER+ breast cancers using machine-learning

Frontiers in Molecular Biosciences(2022)10.3389/fmolb.2022.981962

N/A

0DataRank · unranked

9 citations

Patrick A. Cosgrove, Jeffrey T. Chang, Andrea Bild, Aritro Nath

Cancer cells communicate with macrophages to prevent T cell activation during development of cell cycle therapy resistance

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.09.14.507931

N/A

0DataRank · unranked

3 citations

Patrick A. Cosgrove, Eric Medina Castaneda, Aritro Nath, Jinfeng Chen, Frederick R. Adler +4 more

Unraveling phenotypic plasticity and evolution in small cell lung cancer

Cell Systems(2022)10.1016/j.cels.2022.08.005

N/A

0DataRank · unranked

0 citations

Aritro Nath

Cell facilitation promotes growth and survival under drug pressure in breast cancer

Nature Communications(2023)10.1038/s41467-023-39242-6

N/A

0DataRank · unranked

29 citations

Jason I. Griffiths, Vince Kornél Grolmusz, Aritro Nath, Jinfeng Chen, Eric F. Medina +5 more

Paradoxical cancer cell proliferation after FGFR inhibition through decreased p21 signaling in FGFR1-amplified breast cancer cells

Breast Cancer Research(2024)10.1186/s13058-024-01808-7

N/A

0DataRank · unranked

8 citations

Jason I. Griffiths, Aritro Nath, Andrea Bild, Feng Chi

Single-Cell Transcriptomics Sheds Light on Tumor Evolution: Perspectives from City of Hope’s Clinical Trial Teams

Journal of Clinical Medicine(2024)10.3390/jcm13247507

N/A

0DataRank · unranked

5 citations

Andrea H. Bild, Thanh H. Dellinger, Behnam Badie, Jana Portnow, Aritro Nath +1 more

Cellular interactions within the immune microenvironment underpins resistance to cell cycle inhibition in breast cancers

Nature Communications(2025)10.1038/s41467-025-56279-x

N/A

0DataRank · unranked

20 citations

Patrick A. Cosgrove, Eric F. Medina, Aritro Nath, Jinfeng Chen, Frederick R. Adler +4 more

The Hallmarks of Predictive Oncology

Cancer Discovery(2025)10.1158/2159-8290.cd-24-0760

N/A

0DataRank · unranked

14 citations

Xiaoyu Zhao, Patrick D. Wall, Emily So, G. Calderini, Alexander Partin +17 more

System analysis links SMARCD3 regulons to growth signaling and MEK inhibitor response in everolimus-resistant ER+ breast cancer cells

Cell Reports Medicine(2025)10.1016/j.xcrm.2025.102425

N/A

0DataRank · unranked

1 citations

Elena Farmaki, Jason I. Griffiths, Andrea H. Bild, Aritro Nath, Eric F. Medina

Aritro Nath

Indexed papers

Top data-sharing exemplar

Papers